Ascendis Pharma (ASND) Authorizes $400M Share Buyback
insidermonkey.com · 2026-09-21
On September 14, Ascendis Pharma A/S (NASDAQ:ASND) said its Board had authorized buying back up to $400 million of its own ordinary shares.
Read the full story at insidermonkey.com →
Is ASND undervalued? See TickrTrends' fair value analysis →